CASP1 and epilepsy: Activation of the NLRP3 inflammasome has been detected during epilepsy, and knockdown of NLRP3 or caspase-1 decreased IL-1β and IL-16 levels and provided neuroprotection against SE-associated neuronal damage13,14.